Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB vs MESALAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPOLIZUMAB vs MESALAMINE: Safety Overview

Metric MEPOLIZUMAB MESALAMINE
Total FAERS Reports 43,006 19,475
Deaths Reported 3,158 1,744
Death Rate 7.3% 9.0%
Hospitalizations 13,819 6,015
Average Patient Age 58.9 yrs 49.8 yrs
% Female Patients 67.1% 46.7%
FDA Approval Date N/A Apr 14, 2025
Manufacturer GlaxoSmithKline LLC Upsher-Smith Laboratories, LLC
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription